Периоперационная железодефицитная анемия в акушерстве. Возможности профилактики и коррекции. Обзор литературы
№ 4 (2020) , ИНТЕНСИВНАЯ ТЕРАПИЯ В АКУШЕРСТВЕ
№ 4 (2020)
ИНТЕНСИВНАЯ ТЕРАПИЯ В АКУШЕРСТВЕ

Периоперационная железодефицитная анемия в акушерстве. Возможности профилактики и коррекции. Обзор литературы

https://doi.org/10.21320/1818-474X-2020-4-99-107
Опубликован 16.11.2020
Александр Вениаминович Куликов
ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава Российской Федерации, Екатеринбург, Россия
https://orcid.org/0000-0002-7768-4514
Е.М. Шифман
ГБУЗ МО «Московский областной научно-исследовательский клинический институт имени М.Ф. Владимирского», Москва, Россия
https://orcid.org/0000-0002-6113-8498
А.А. Матковский
ГАУЗ СО «Областная детская клиническая больница», Екатеринбург, Россия
https://orcid.org/0000-0002-2920-917X
А.В. Каюмова
ГАУЗ СО «Областная детская клиническая больница», Екатеринбург, Россия
https://orcid.org/0000-0003-2685-4285
А.М. Роненсон
https://orcid.org/0000-0002-2468-297X
#2020-4
PDF_2020-04_99-107
HTML_2020-04_99-107

Ключевые слова

менеджмент крови
акушерство
дефицит железа
железодефицитная анемия
беременность
внутривенное железо

Как цитировать

Куликов А.В., Шифман Е.М., Матковский А.А., Каюмова А.В., Роненсон А.М. Периоперационная железодефицитная анемия в акушерстве. Возможности профилактики и коррекции. Обзор литературы. Вестник интенсивной терапии имени А.И. Салтанова. 2020;(4):99–107. doi:10.21320/1818-474X-2020-4-99-107.
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA ГОСТ

Скачать ссылку

Endnote/Zotero/Mendeley (RIS) BibTeX

Статистика

Просмотров аннотации: 73
PDF_2020-04_99-107 загрузок: 13
HTML_2020-04_99-107 загрузок: 121
Статистика с 21.01.2023

Язык

English Русский

Объявления

Мы в соцсетях

Аннотация

В обзоре рассматривается диагностика и коррекция железодефицитной анемии во время беременности и в периоперационном периоде в рамках концепции «менеджмента крови пациента». Обсуждаются особенности диагностики анемии и верификации железодефицитного состояния во время беременности, этапы коррекции с использованием пероральных и внутривенных препаратов железа, трансфузии аллогенных эритроцитов и аппаратной реинфузии крови. Представлены данные о преимуществе внутривенных препаратов железа для коррекции железодефицитного состояния и железодефицитной анемии во время беременности и в периоперационном периоде.
https://doi.org/10.21320/1818-474X-2020-4-99-107
PDF_2020-04_99-107
HTML_2020-04_99-107

Библиографические ссылки

  1. World Health Organization — IDA. Available from: https://www.who.int/nutrition/topics/ida/en/ (accessed 29.06.2020).
  2. Muñoz M., Acheson A.G., Bisbe E., et al. An international consensus statement on the management of postoperative anaemia after major surgical procedures. Anaesthesia. 2018; 73(11): 1418–1431. DOI: 10.1111/anae.14358
  3. Warner M.A., Shore-Lesserson L., Shander A., et al. Perioperative Anemia: Prevention, Diagnosis, and Management Throughout the Spectrum of Perioperative Care. Anesth Analg. 2020; 130(5): 1364–1380.
  4. Meybohm P., Neef V., Westphal S., et al. Preoperative iron deficiency with/without anemia-an underestimated risk factor? Chirurg. 2020; 91(2): 109–114.
  5. Lasocki S., Pène F., Ait-Oufella H., et al. Management and prevention of anemia (acute bleeding excluded) in adult critical care patients. Anaesth Crit Care Pain Med. 2020; S2352–5568(20)30070-9. DOI: 10.1016/j.accpm.2020.04.004
  6. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015; 122(2): 241–275.
  7. Mueller M.M., Van Remoortel H., Meybohm P., et al. Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. JAMA. 2019; 321(10): 983–9.
  8. Casans Francés R., Ripollés Melchor J., Calvo Vecino J.M.; Grupo Español de Rehabilitación Multimodal GERM/ERAS-Spain. Is it time to integrate patient blood management in ERAS guidelines? Rev Esp Anestesiol Reanim. 2015; 62(2): 61–63. DOI: 10.1016/j.redar.2014.12.005
  9. Wilson R.D., Caughey A.B., Wood S.L., et al. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1). Am J Obstet Gynecol. 2018; 219(6): 523.e1–523.e15. DOI: 10.1016/j.ajog.2018.09.015
  10. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1) Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf (accessed 15.10.2020).
  11. Pavord S., Myers B., Robinson S., et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012; 156(5): 588–600. DOI: 10.1111/j.1365-2141.2011.09012.x.
  12. Aguree S., Gernand A.D. Plasma volume expansion across healthy pregnancy: a systematic review and meta-analysis of longitudinal studies. BMC Pregnancy Childbirth. 2019; 19(1): 508. DOI: 10.1186/s12884-019-2619-6
  13. Means R.T. Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters. Nutrients. 2020; 12(2): 447. DOI: 10.3390/nu12020447
  14. Guignard J., Deneux-Tharaux C., Seco A., et al. EPIMOMS group. Gestational anaemia and severe acute maternal morbidity: a population-based study. Anaesthesia. 2020; Aug 26. DOI: 10.1111/anae.15222
  15. Smith C., Teng F., Branch E., et al. Maternal and Perinatal Morbidity and Mortality Associated with Anemia in Pregnancy. Obstet Gynecol. 2019; 134(6): 1234–1244. DOI: 10.1097/AOG.0000000000003557
  16. Ray J.G., Davidson A., Berger H., et al. Haemoglobin levels in early pregnancy and severe maternal morbidity: population-based cohort study. BJOG. 2020; Mar 16.
  17. Vander Meulen H., Strauss R., Lin Y., et al. The contribution of iron deficiency to the risk of peripartum transfusion: a retrospective case control study BMC Pregnancy Childbirth. 2020; 20(1): 196. DOI: 10.1186/s12884-020-02886-z
  18. Ferguson M.T., Dennis A.T. Defining peri-operative anaemia in pregnant women — challenging the status quo. Anaesthesia. 2019; 74(2): 237–245. DOI: 10.1111/anae.14468
  19. Aparicio E., Jardí C., Bedmar C., et al. Nutrient Intake during Pregnancy and Post-Partum: ECLIPSES Study. Nutrients. 2020; 12(5): E1325. DOI: 10.3390/nu12051325
  20. Milman N.T. Dietary Iron Intake in Pregnant Women in Europe: A Review of 24 Studies from 14 Countries in the Period 1991–2014. J Nutr Metab. 2020 Feb 24; 2020: 7102190. DOI: 10.1155/2020/7102190
  21. Fisher A.L., Nemeth E. Iron homeostasis during pregnancy. Am J Clin Nutr. 2017; 106(Suppl 6): 1567S–1574S.
  22. Muñoz M., Peña-Rosas J.P., Robinson S., et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med. 2018; 28(1): 22–39.
  23. Georgieff M.K. Iron deficiency in pregnancy. Am J Obstet Gynecol. 2020; S0002–9378(20)30328–8. DOI: 10.1016/j.ajog.2020.03.006
  24. Dewey K.G., Oaks B.M. U-shaped curve for risk associated with maternal hemoglobin, iron status, or iron supplementation. Am J Clin Nutr. 2017; 106(Suppl 6): 1694S–1702S. DOI: 10.3945/ajcn.117.156075
  25. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations [Internet]. Available from: https://www.who.int/publications-detail/9789240000124 (accessed 21.05.2020).
  26. Auerbach M., Adamson J.W. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016; 91(1): 31–38. DOI: 10.1002/ajh.24201
  27. Cappellini M.D., Comin-Colet J., de Francisco A., et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017; 92(10): 1068–1078.
  28. Zdanowicz J.A., Surbek D. Patient blood management in obstetrics — Review. Transfus Apher Sci. 2019 Aug; 58(4): 412–415.
  29. Shaylor R., Weiniger C.F., Austin N., et al. National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review. Anesth Analg. 2017; 124(1): 216–232. DOI: 10.1213/ANE.0000000000001473
  30. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience. Geneva: World Health Organization, 2016.
  31. Tran K., McCormack S. Screening and Treatment of Obstetric Anemia: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2019.
  32. Guideline: Daily Iron Supplementation in Adult Women and Adolescent Girls. Geneva: World Health Organization, 2016. Available from: https://www.who.int/nutrition/publications/micronutrients/guidelines/daily_iron_supp_womenandgirls.pdf?ua = 1 (accessed 15.10.2020).
  33. Kuruvilla S., Bustreo F., Kuo T., et al. The Global strategy for women’s, children’s and adolescents’ health (2016–2030): a roadmap based on evidence and country experience. Bull World Health Organ. 2016; 94(5): 398–400. DOI: 10.2471/BLT.16.170431
  34. Schaefer B., Meindl E., Wagner S., et al. Intravenous iron supplementation therapy. Mol Aspects Med. 2020; 100862. DOI: 10.1016/j.mam.2020.100862
  35. Qassim A., Grivell R.M., Henry A., et al. Intravenous or oral iron for treating iron deficiency anaemia during pregnancy: systematic review and meta-analysis. Med J Aust. 2019; 211(8): 367–373.
  36. Lewkowitz A.K., Gupta A., Simon L., et al. Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis. J Perinatol. 2019; 39(4): 519–532.
  37. Govindappagari S., Burwick R.M. Treatment of Iron Deficiency Anemia in Pregnancy with Intravenous versus Oral Iron: Systematic Review and Meta-Analysis. Am J Perinatol. 2019; 36(4): 366–376.
  38. Auerbach M., Gafter-Gvili A., Macdougall I.C. Intravenous iron: a framework for changing the management of iron deficiency. Lancet Haematol. 2020; 7(4): e342–e350. DOI: 10.1016/S2352-3026(19)30264-9
  39. Приложение № 1 к распоряжению Правительства Российской Федерации от 12 октября 2019 года N 2406-р «Перечень жизненно необходимых и важнейших лекарственных препаратов для медицинского применения на 2020 год» [Электронный ресурс]. Режим доступа: https://base.garant.ru/72861778/53f89421bbdaf741eb2d1ecc4ddb4c33. Ссылка активна на 15.10.2020. [Prilozhenie № 1 k rasporyazheniyu Pravitel’stva Rossijskoj Federacii ot 12 oktyabrya 2019 goda N 2406-r “Perechen’ zhiznenno neobhodimyh i vazhnejshih lekarstvennyh preparatov dlya medicinskogo primeneniya na 2020 god” [Elektronnyj resurs]. Available from: https://base.garant.ru/72861778/53f89421bbdaf741eb2d1ecc4ddb4c33/ (accessed 15.10.2020). (In Russ)]
  40. Jose A., Mahey R., Sharma J.B., et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy-randomised controlled trial. BMC Pregnancy Childbirth. 2019; 19(1): 54. DOI: 10.1186/s12884-019-2200-3
  41. Khalafallah A.A., Hyppa A., Chuang A., et al. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. Semin Hematol. 2018; 55(4): 223–234. DOI: 10.1053/j.seminhematol.2018.04.006
  42. Wani S., Noushad M., Ashiq S. REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women. Anemia. 2019: 4640635. DOI: 10.1155/2019/4640635
  43. Froessler B., Gajic T., Dekker G., Hodyl N.A. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Arch Gynecol Obstet. 2018; 298(1): 75–82.
  44. Daniilidis A., Panteleris N., Vlachaki E., Breymann C., Assimakopoulos E. Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review. J Obstet Gynaecol. 2018; 38(4): 443–447.
  45. Breymann C., Honegger C., Hösli I., Surbek D. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum. Arch Gynecol Obstet. 2017; 296(6): 1229–1234.
  46. Wesström J. Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy. Arch Gynecol Obstet. 2020; 301(5): 1127–1131. DOI: 10.1007/s00404-020-05509-2
  47. Iyoke C.A., Emegoakor F.C., Ezugwu E.C., et al. Effect of treatment with single total-dose intravenous iron versus daily oral iron(III)-hydroxide polymaltose on moderate puerperal iron-deficiency anemia. Ther Clin Risk Manag. 2017; 13: 647–653. DOI: 10.2147/TCRM.S112227
  48. Holm C., Thomsen L.L., Langhoff-Roos J. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage. J Matern Fetal Neonatal Med. 2019; 32(17): 2797–2804. DOI: 10.1080/14767058.2018.1449205
  49. Shi Q., Leng W., Wazir R., et al. Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review. Gynecol Obstet Invest. 2015; 80(3): 170–178. DOI: 10.1159/000376577
  50. Bhavi S.B., Jaju P.B. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial. BMC Pregnancy Childbirth. 2017; 17(1): 137. DOI: 10.1186/s12884-017-1313-9
  51. Neogi S.B., Devasenapathy N., Singh R., et al. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Glob Health. 2019; 7(12): e1706–e1716. DOI: 10.1016/S2214-109X(19)30427-9
  52. Guideline: Iron Supplementation in Postpartum Women. Geneva: World Health Organization, 2016 [Internet]. Available from: https://apps.who.int/iris/handle/10665/249242 (accessed 15.10.2020).
  53. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017; 130(4): e168–e186. DOI: 10.1097/AOG.0000000000002351
  54. Shaji Geetha N., Bobby Z., Dorairajan G., Jacob S.E. Increased hepcidin levels in preeclampsia: a protective mechanism against iron overload mediated oxidative stress? J Matern Fetal Neonatal Med. 2020; 1–6. DOI: 10.1080/14767058.2020.1730322
  55. Mannaerts D., Faes E., Cos P., et al. Oxidative stress in healthy pregnancy and preeclampsia is linked to chronic inflammation, iron status and vascular function. PLoS One. 2018; 13(9): e0202919. DOI: 10.1371/journal.pone.0202919
  56. Silva J.V.F., Ferreira R.C., Tenório M.B., et al. Hyperferritinemia worsens the perinatal outcomes of conceptions of pregnancies with preeclampsia. Pregnancy Hypertens. 2020; 19: 233–238. DOI: 10.1016/j.preghy.2019.11.004
  57. Goucher H., Wong C.A., Patel S.K., Toledo P. Cell Salvage in Obstetrics. Anesth Analg. 2015; 121(2): 465–468. DOI: 10.1213/ANE.0000000000000786
  58. Sullivan I.J., Ralph C.J. Obstetric intra-operative cell salvage: a review of an established cell salvage service with 1170 re-infused cases. Anaesthesia. 2019; 74(8): 976–983. DOI: 10.1111/anae.14630
  59. Pacheco L.D., Gei A.F. Controversies in the management of placenta accreta. Obstet Gynecol Clin North Am. 2011; 38(2): 313-xi. DOI: 10.1016/j.ogc.2011.02.018
  60. Royal College of Obstetricians and Gynaecologists Blood Transfusion in Obstetrics Green-top Guideline. 2015 May; 47: 23.
  61. Sentilhes L., Vayssière C., Deneux-Tharaux C., et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016; 198: 12–21. DOI: 10.1016/j.ejogrb.2015.12.012
Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-ShareAlike» («Атрибуция — Некоммерческое использование — На тех же условиях») 4.0 Всемирная.

Наиболее читаемые статьи этого автора (авторов)

1 2 3 > >>